[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-350068-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-350068-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","ipepgen-a-modular-immunopeptidogenomic-analysis-pipeline-for-discovery-verification-and-prioritization-of-cancer-peptide-neoantigen-candidates","iPepGen: a modular, immunopeptidogenomic analysis pipeline for discovery, verification, and prioritization of cancer peptide neoantigen candidates","","Characterizing tumor-specific neoantigen peptides, derived from genomic or transcriptomic aberrations and presented to the immune system, is critical for immunooncology studies. The modular iPepGen immunopeptidogenomics pipeline supports neoantigen prediction and protein database generation, peptide identification and verification from immunopeptidomic mass spectra, classification and visualization, and candidate prioritization for further study. A scalable cloud gateway and interactive training materials enable adoption by researchers with limited computational expertise and resources.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/ipepgen-a-modular-immunopeptidogenomic-analysis-pipeline-for-discovery-verification-and-prioritization-of-cancer-peptide-neoantigen-candidates/350068/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/ipepgen-a-modular-immunopeptidogenomic-analysis-pipeline-for-discovery-verification-and-prioritization-of-cancer-peptide-neoantigen-candidates/350068.png","ImageObject",300,407,{"name":42,"@type":43},"Kyle","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-27","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What does the iPepGen pipeline provide for neoantigen research?","Question",{"text":63,"@type":64},"It supports neoantigen prediction and protein database generation, peptide identification and verification from immunopeptidomic mass spectral data, classification and visualization, and candidate prioritization for further study.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"From where are neoantigen peptides derived in this work?",{"text":68,"@type":64},"Neoantigen peptides come from tumor-associated genomic or transcriptomic aberrations, including mechanisms such as mutations, gene fusions, aberrant splicing, de novo transcription, transposable element derepression, post-translational modifications, and viral open reading frame translation.",{"name":70,"@type":61,"acceptedAnswer":71},"How does iPepGen help researchers who lack advanced computational expertise?",{"text":72,"@type":64},"It offers easy access through a publicly available, scalable cloud-based gateway and online interactive training materials that streamline immunopeptidogenomic analysis adoption.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},350068,1790395896,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},3985741905716,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Mehta et al. Genome Biology (2026) 27:111 [https://doi.org/10.1186/s13059-026-04012-2](https://doi.org/10.1186/s13059-026-04012-2)  \nGenome Biology  \nSOFTWARE Open Access  \niPepGen: a modular, immunopeptidogenomic   analysis pipeline for discovery, verification, and prioritization of cancer peptide neoantigen candidates  \nSubina Mehta 1, Reid Wagner2, Katherine T. Do 1, James E. Johnson2^, Fengchao Yu3, Tyler Jubenville4, Kyle Richards5, Suzanne Coleman4, Flavia E. Popescu4, Alexey I. Nesvizhskii3,6, David A. Largaespada4,5, Pratik D. Jagtap 1,4 and Timothy J. Griffin 1,4*  \n*Correspondence: [tgriffin@umn.edu](tgriffin@umn.edu)  \n1 Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, USA 2 Minnesota Supercomputing Institute, University of Minnesota, Minneapolis, USA  \n3 Department of Pathology, University of Michigan, Ann Arbor, USA  \n4 Masonic Cancer Center, University of Minnesota, Minneapolis, USA  \n5 Department of Pediatrics, University of Minnesota, Minneapolis, USA  \n6 Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, USA  \nAbstract  \nCharacterizing tumor-specific neoantigen peptides, derived from genomic or transcriptomic aberrations and presented to the immune system, is critical for immunooncology studies. To this end, the modular iPepGen immunopeptidogenomics pipeline provides these functions: (1) Neoantigen prediction and protein database generation from genomic or transcriptomic sequencing data; (2) Peptide identification (3) Verification from immunopeptidomic mass spectral data; (4) Neoantigen classification and visualization; (5) Candidate prioritization for further study. Easy access via a publicly available, scalable cloud-based gateway coupled with online, interactive training materials streamlines the adoption by cancer researchers who require immunopeptidogenomic analysis tools but lack advanced computational expertise and resources. Keywords: Neoantigen, Immunopeptidomics, Immuno-oncology, Mass spectrometry, Next-generation sequencing, Multi-omics, Galaxy, Bioinformatics, Workflow  \nBackground  \nNeoantigen peptides, derived from non-reference proteoforms uniquely expressed in tumor cells, are an increasingly important class of targets in cancer immunotherapy. These proteoforms may arise from a variety of genomic, transcriptomic, and post-translational mechanisms, including non-synonymous mutations, gene fusions [1], aberrant splicing, de novo transcription from non-coding regions [2], derepression of transposable elements, post-translational modification (PTM) [3], and translation of viral open reading frames in virus-associated cancers [4]. These alterations yield tumor-specific antigens absent from normal tissues and thus bypass central tolerance [5–8]. In addition to neoantigens, tumor-associated antigens (TAAs) and tumor-specific antigens (TSAs)  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-n","cbCaidDdraYehKE0","https://ap.wps.com/l/cbCaidDdraYehKE0","pdf",2833851,31,"English","# Abstract\n# Background\n## Neoantigen biology and origin\n## Antigen presentation and immunogenicity\n## Immunotherapy opportunities\n# Identifying and predicting neoantigen candidates from genomic and transcriptomic data\n## Role of NGS and computational pipelines","[{\"question\":\"What does the iPepGen pipeline provide for neoantigen research?\",\"answer\":\"It supports neoantigen prediction and protein database generation, peptide identification and verification from immunopeptidomic mass spectral data, classification and visualization, and candidate prioritization for further study.\"},{\"question\":\"From where are neoantigen peptides derived in this work?\",\"answer\":\"Neoantigen peptides come from tumor-associated genomic or transcriptomic aberrations, including mechanisms such as mutations, gene fusions, aberrant splicing, de novo transcription, transposable element derepression, post-translational modifications, and viral open reading frame translation.\"},{\"question\":\"How does iPepGen help researchers who lack advanced computational expertise?\",\"answer\":\"It offers easy access through a publicly available, scalable cloud-based gateway and online interactive training materials that streamline immunopeptidogenomic analysis adoption.\"}]","iPepGen: a modular, immunopeptidogenomic analysis pipeline for discovery, verification, and prioritization of cancer peptide neoantigen candidates | PDF",1790086986,78,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/82bd1d48efc0e3f37c0d6e7d6073929e.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/73363e6b6382018ebc403f8367aae1ac.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/84e72b3c26551927eef0ffc7107b228a.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/60e6fdf8a5a9c10e463fe4c2cdff7864.webp",980,1301]